Lv4
510 积分 2025-01-08 加入
Amphiregulin in cellular physiology, health, and disease: Potential use as a biomarker and therapeutic target
2天前
已完结
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
4天前
已完结
Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
4天前
已完结
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development
4天前
已完结
Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study
7天前
已完结
Driver and targetable alterations in Chinese patients with small bowel carcinoma
7天前
已完结
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies
9天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
9天前
已完结
Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply
9天前
已完结
Immunotherapy in Gastric Cancer—Choosing Methods or Results
9天前
已完结
皖公网安备34019202002308
